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hyperalgesia. Furthermore, they suggested that
remifentanil in association with ketamine was useflil
in patients pretreated with opioids.
One possibility for this patient's pain in the
postoperative period — and in our view the most
likely one - however is not discussed, namely opioid-
withdrawal hyperalgesia. Postoperative analgesia in
patients who receive opioids for chronic pain is
undoubtedly a challenge for anaesthesiologists and
pain therapists. In clinical practice, chronic pain
patients receiving strong opioids preoperatively show
high inter-individual variability and sometimes
extremely high postoperative demand for opioids.
Depending on the chronic opioid dose, total ctimu-
lative doses of 30-45 mg piritramide within the
first 1-2 h are common in these patients. These
observations are in accordance with Rapp and
colleagues [2], who found a more than three-fold
(135.8 vs. 42.8 mg) increase in opioid demand in the
first 24 h after surgery in patients with preoperative
opioid consumption as compared with opioid-naive
patients.
In addition, we feel that postoperative analgesia
is much more difficult to handle in chronic pain
patients receiving remifentanil as sole opioid
intraoperatively as compared with those receiving
long-acting |x-opioid agonists like fentanyl or
sufentanil. Irrespective of the fact whether this
patient's fentanyl patch was removed before surgery
or not, we feel that the administration of 10 mg
piritramide and 4mg morphine for postoperative
analgesia in this patient was simply not enough to
provide sufficient analgesia.
It has been shown that enhanced pain sensations
after cessation of a remifentanil infusion are due to an
acute withdrawal response,, which cannot be modu-
lated by N-methyl-D-aspartic acid receptor antago-
nists [3,4]. Therefore, we think that the therapeutic
effect of ketamine observed by Dumont and collea-
gues is most likely due to its direct analgesic or
hypnotic effect and not based on the reversal of
pronociceptive mechanisms induced by remifentanil.
The increasing evidence for opioid-induced hyper-
algesia should not lead to a restricted use of opioids
in the perioperative period, especially not in patients
who have a history of chronic opioid administration.
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Comparison of LMA Unique, Ambu laryngeal mask and Soft
Seal laryngeal mask during routine surgical procedures
doi: 10.1017/S0265021507000518
EDITOR:
We read with interest the paper by Francksen and
colleagues [1] comparing the LMA Unique, Ambu
laryngeal mask and Soft Seal laryngeal mask. In a
randomized controlled study, we compared the
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performance of the LMA Unique with the Soft Seal
laryngeal mask and the Cobra Perilaryngeal Airway
[2]. We studied 320 consecutive patients in the
three groups and found that the LMA Unique and
Soft Seal laryngeal mask were of equal clinical
performance. Ease of insertion between the two
devices was very similar using a partially inflated
cuff. In the Unique LMA group, a successful pri-
mary airway was established in 96% of patients on
the first attempt, and in 4% of patients insertion
failed at the second attempt. In the Soft Seal
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laryngeal mask group, a successful primary airway
was established in 99% of patients on the first
attempt, and in 1% of patients insertion failed at
the second attempt. In agreement with the authors,
the effective airway time was similar for the two
devices and the oropharyngeal leak pressure was
higher in the Soft Seal laryngeal mask group. The
endoscopic score of the larynx was significantly
better with the Soft Seal laryngeal mask group than
with the Unique LMA group. The changes in cuff
pressures and airway morbidity were similar in both
groups.
In an observational study, we inserted the Soft
Seal laryngeal mask with the cuff inflated at
atmospheric pressure [3] in 100 patients and
achieved 97% success in the first attempt and 3% in
the second attempt. Regarding insertions, 85%
were graded as very easy and 12% as easy and were
achieved within 20 s. The mean intra-cuff pressure
in vivo was 40 mmHg (53 cm H2O). The leak
pressure was at a mean pressure of 24.8 cm H2O, in
agreement with the authors. Only six patients
complained of mild-to-moderate sore throat in the
first 2 h after operation.
We agree with the authors' conclusion that the
LMA Unique and the Soft Seal laryngeal mask are of
equal clinical suitability. We believe that inserting
the Soft Seal laryngeal mask with the cuff infiated at
atmospheric pressure can achieve excellent condi-
tions for insertion and removal.
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Conditions involving release of pro-inflammatory cytokines
predispose to ARDS
doi: 10.1017/S026502150700049X
EDITOR:
Sadis and colleagues [1] investigated risk factors for
the development of ARDS in patients receiving
multiple transfusions and found that it was not the
number of transfusions but thoracic trauma and
hypoxia that were associated with the subsequent
development of ARDS. Patients who developed
ARDS received significantly more fresh frozen
plasma. Previous studies showed that septicaemia is
an additional predisposing factor for transfusion-
related ARDS [2]. Another condition commonly
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associated with pulmonary oedema during infusion
of large amounts of intravenous fiuids is diabetic
ketoacidosis [3]. All these conditions with their
different pathophysiology have in common the
release of large amounts of cytokines including
tumour necrosis factor (TNF) and interleukin-1
(IL-1). Transfusion of an anti-CD28 monoclonal
antibody into human volunteers stimulated T-cells
to release large amounts of these two cytokines and
led to pulmonary oedema in all subjects of this trial
[4]. The mechanism by which these cytokines lead
to or predispose to pulmonary oedema bas recently
been clarified: Alveolar epithelial fluid clearance in
pulmonary oedema is dependent on pulmonary
epithelial sodium and chloride transport through
the apical alveolar epithelial sodium channel and
the cystic fibrosis transmembrane conductance
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